The Medicines and Healthcare products Regulatory Agency (MHRA) has warned that sellers of fake Botox injections could face up to two years in prison and unlimited fines, as it intensifies efforts to crack down on unlicensed botulinum toxin products following a spate of botulism cases in England.
Between 4 June and 6 August 2025, 41 people are believed to have been affected by botulism, a potentially fatal condition that can cause paralysis if untreated. The MHRA attributes these cases to the illegal trade of unlicensed anti-wrinkle products.
Andy Morling, head of the MHRA’s criminal enforcement unit, stated: “Criminals are exploiting the popularity of cosmetic treatments by peddling dangerous, unlicensed products, putting profit before safety. The 41 individuals left seriously ill represent the devastating human cost of this trade.”
Since May 2023, the MHRA, working with Border Force, has seized over 4,700 vials of unlicensed botulinum toxin, mostly from South Korea. Among the seized products is Innotox, a Botox-like medication not licensed in the UK, which experts warn has led some to attempt DIY injections, risking eyelid droops, infections, tissue damage, and botulism.
Aenone Harper-Machin, a consultant plastic surgeon and Bapras spokesperson, welcomed the MHRA’s action, saying: “Botulinum toxin is a prescription-only medicine that should only be administered in a clinical environment by qualified healthcare professionals. When used improperly, it can cause devastating and even life-threatening complications.”
